These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 35976655)

  • 1. Understanding Connections and Boundaries Between Positive Symptoms, Negative Symptoms, and Role Functioning Among Individuals With Schizophrenia: A Network Psychometric Approach.
    Abplanalp SJ; Braff DL; Light GA; Nuechterlein KH; Green MF;
    JAMA Psychiatry; 2022 Oct; 79(10):1014-1022. PubMed ID: 35976655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interplay Among Psychopathologic Variables, Personal Resources, Context-Related Factors, and Real-life Functioning in Individuals With Schizophrenia: A Network Analysis.
    Galderisi S; Rucci P; Kirkpatrick B; Mucci A; Gibertoni D; Rocca P; Rossi A; Bertolino A; Strauss GP; Aguglia E; Bellomo A; Murri MB; Bucci P; Carpiniello B; Comparelli A; Cuomo A; De Berardis D; Dell'Osso L; Di Fabio F; Gelao B; Marchesi C; Monteleone P; Montemagni C; Orsenigo G; Pacitti F; Roncone R; Santonastaso P; Siracusano A; Vignapiano A; Vita A; Zeppegno P; Maj M;
    JAMA Psychiatry; 2018 Apr; 75(4):396-404. PubMed ID: 29450447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two and five-factor models of negative symptoms in schizophrenia are differentially associated with trait affect, defeatist performance beliefs, and psychosocial functioning.
    Paul NB; Strauss GP; Gates-Woodyatt JJ; Barchard KA; Allen DN
    Eur Arch Psychiatry Clin Neurosci; 2023 Dec; 273(8):1715-1724. PubMed ID: 36633673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling Deficits From Early Auditory Information Processing to Psychosocial Functioning in Schizophrenia.
    Thomas ML; Green MF; Hellemann G; Sugar CA; Tarasenko M; Calkins ME; Greenwood TA; Gur RE; Gur RC; Lazzeroni LC; Nuechterlein KH; Radant AD; Seidman LJ; Shiluk AL; Siever LJ; Silverman JM; Sprock J; Stone WS; Swerdlow NR; Tsuang DW; Tsuang MT; Turetsky BI; Braff DL; Light GA
    JAMA Psychiatry; 2017 Jan; 74(1):37-46. PubMed ID: 27926742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative Symptom Inventory-Self-Report (NSI-SR): Initial development and validation.
    Raugh IM; Luther L; Bartolomeo LA; Gupta T; Ristanovic I; Pelletier-Baldelli A; Mittal VA; Walker EF; Strauss GP
    Schizophr Res; 2023 Jun; 256():79-87. PubMed ID: 37172500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized trial to evaluate the efficacy of cognitive therapy for low-functioning patients with schizophrenia.
    Grant PM; Huh GA; Perivoliotis D; Stolar NM; Beck AT
    Arch Gen Psychiatry; 2012 Feb; 69(2):121-7. PubMed ID: 21969420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Negative symptoms and everyday functioning in schizophrenia: a cross-sectional study in a real world-setting.
    Rocca P; Montemagni C; Zappia S; Piterà R; Sigaudo M; Bogetto F
    Psychiatry Res; 2014 Aug; 218(3):284-9. PubMed ID: 24814140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Negative symptoms in bipolar disorder and schizophrenia: A psychometric evaluation of the brief negative symptom scale across diagnostic categories.
    Strauss GP; Vertinski M; Vogel SJ; Ringdahl EN; Allen DN
    Schizophr Res; 2016 Feb; 170(2-3):285-9. PubMed ID: 26742510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors Associated With Real-Life Functioning in Persons With Schizophrenia in a 4-Year Follow-up Study of the Italian Network for Research on Psychoses.
    Mucci A; Galderisi S; Gibertoni D; Rossi A; Rocca P; Bertolino A; Aguglia E; Amore M; Bellomo A; Biondi M; Blasi G; Brasso C; Bucci P; Carpiniello B; Cuomo A; Dell'Osso L; Giordano GM; Marchesi C; Monteleone P; Niolu C; Oldani L; Pettorruso M; Pompili M; Roncone R; Rossi R; Tenconi E; Vita A; Zeppegno P; Maj M;
    JAMA Psychiatry; 2021 May; 78(5):550-559. PubMed ID: 33566071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mirtazapine adjunct for people with schizophrenia.
    Perry LA; Ramson D; Stricklin S
    Cochrane Database Syst Rev; 2018 May; 5(5):CD011943. PubMed ID: 29802811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disorganization and real-world functioning in schizophrenia: Results from the multicenter study of the Italian Network for Research on Psychoses.
    Rocca P; Galderisi S; Rossi A; Bertolino A; Rucci P; Gibertoni D; Montemagni C; Bellino S; Aguglia E; Amore M; Bellomo A; Biondi M; Carpiniello B; Cuomo A; D'Ambrosio E; dell'Osso L; Girardi P; Marchesi C; Monteleone P; Montemitro C; Oldani L; Pacitti F; Roncone R; Siracusano A; Tenconi E; Vita A; Zeppegno P; Steardo L; Vignapiano A; Maj M;
    Schizophr Res; 2018 Nov; 201():105-112. PubMed ID: 29898819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network Analysis Reveals Which Negative Symptom Domains Are Most Central in Schizophrenia vs Bipolar Disorder.
    Strauss GP; Esfahlani FZ; Kirkpatrick B; Allen DN; Gold JM; Visser KF; Sayama H
    Schizophr Bull; 2019 Oct; 45(6):1319-1330. PubMed ID: 30649527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of positive and negative symptoms in schizophrenia. A study from a population of long-term outpatients.
    Palacios-Araus L; Herrán A; Sandoya M; González de la Huebra E; Vázquez-Barquero JL; Díez-Manrique JF
    Acta Psychiatr Scand; 1995 Sep; 92(3):178-82. PubMed ID: 7484194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Latent Structure of Negative Symptoms in Schizophrenia.
    Strauss GP; Nuñez A; Ahmed AO; Barchard KA; Granholm E; Kirkpatrick B; Gold JM; Allen DN
    JAMA Psychiatry; 2018 Dec; 75(12):1271-1279. PubMed ID: 30208377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network Analysis Reveals the Latent Structure of Negative Symptoms in Schizophrenia.
    Strauss GP; Esfahlani FZ; Galderisi S; Mucci A; Rossi A; Bucci P; Rocca P; Maj M; Kirkpatrick B; Ruiz I; Sayama H
    Schizophr Bull; 2019 Sep; 45(5):1033-1041. PubMed ID: 30256991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Symptomatic remission and its relationship to social functioning in Tunisian out-patients with schizophrenia].
    El Gharbi I; Chhoumi M; Mechri A
    Encephale; 2019 Feb; 45(1):15-21. PubMed ID: 29195805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of the COVID-19 pandemic on negative symptoms in individuals at clinical high-risk for psychosis and outpatients with chronic schizophrenia.
    Strauss GP; Macdonald KI; Ruiz I; Raugh IM; Bartolomeo LA; James SH
    Eur Arch Psychiatry Clin Neurosci; 2022 Feb; 272(1):17-27. PubMed ID: 33881621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay among positive and negative symptoms, neurocognition, social cognition, and functioning in clinically stable patients with schizophrenia: a network analysis.
    Charernboon T
    F1000Res; 2021; 10():1258. PubMed ID: 35464178
    [No Abstract]   [Full Text] [Related]  

  • 20. Neurophysiological correlates of Avolition-apathy in schizophrenia: A resting-EEG microstates study.
    Giordano GM; Koenig T; Mucci A; Vignapiano A; Amodio A; Di Lorenzo G; Siracusano A; Bellomo A; Altamura M; Monteleone P; Pompili M; Galderisi S; Maj M;
    Neuroimage Clin; 2018; 20():627-636. PubMed ID: 30202724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.